| Dr Howard Jorge Balbi, MD | |
|
655 Deer Park Ave, Babylon, NY 11702-1314 | |
| (631) 321-2100 | |
| (631) 321-2246 |
| Full Name | Dr Howard Jorge Balbi |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Infectious Diseases |
| Location | 655 Deer Park Ave, Babylon, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942201900 | NPI | - | NPPES |
| 01349164 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0208X | Pediatrics - Pediatric Infectious Diseases | 169623 (New York) | Primary |
| Entity Name | Nassau Health Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902822992 PECOS PAC ID: 2961315221 Enrollment ID: O20040619000043 |
News Archive
Aegera Therapeutics Inc. released today encouraging survival data from the Phase 1 portion of its Phase 1-2 Study of the novel targeted therapeutic, AEG35156, given in combination with sorafenib in patients with advanced hepatocellular carcinoma (primary liver cancer).
Over 6,500 new cases of bladder cancer in Europe are caused by exposure to chemicals called trihalomethanes (THM) found in drinking water. This number adds up to almost 5% of all bladder cancers in the continent. The study, published in the journal Environmental Health Perspectives in January 2020, is a pioneering attempt to establish the levels of these chemicals in tap water supplied in 26 countries in the European Union.
Gen-Probe Incorporated today announced that the US Food and Drug Administration (FDA) has granted an EUA (emergency use authorization) for its test, the Prodesse ProFlu-ST(TM), to be used in CLIA high complexity laboratories for the diagnosis of 2009 H1N1 influenza virus infection, aided by an algorithm that relies on seasonal influenza A/H1 virus and seasonal influenza A/H3 virus results, from a single sample in individuals who are diagnosed with influenza A by currently available FDA-cleared or authorized devices.
The dissertation focuses on how individual non-citizens residing illegally in the country perceive their health status, what wishes they have regarding healthcare, and whether these wishes are fulfilled. The individual perspective is used instead of the more common concepts of health and healthcare needs, which are based more on the care-giver perspective.
› Verified 5 days ago
| Entity Name | Samaritan Pediatric Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730308925 PECOS PAC ID: 7618151887 Enrollment ID: O20110413000020 |
News Archive
Aegera Therapeutics Inc. released today encouraging survival data from the Phase 1 portion of its Phase 1-2 Study of the novel targeted therapeutic, AEG35156, given in combination with sorafenib in patients with advanced hepatocellular carcinoma (primary liver cancer).
Over 6,500 new cases of bladder cancer in Europe are caused by exposure to chemicals called trihalomethanes (THM) found in drinking water. This number adds up to almost 5% of all bladder cancers in the continent. The study, published in the journal Environmental Health Perspectives in January 2020, is a pioneering attempt to establish the levels of these chemicals in tap water supplied in 26 countries in the European Union.
Gen-Probe Incorporated today announced that the US Food and Drug Administration (FDA) has granted an EUA (emergency use authorization) for its test, the Prodesse ProFlu-ST(TM), to be used in CLIA high complexity laboratories for the diagnosis of 2009 H1N1 influenza virus infection, aided by an algorithm that relies on seasonal influenza A/H1 virus and seasonal influenza A/H3 virus results, from a single sample in individuals who are diagnosed with influenza A by currently available FDA-cleared or authorized devices.
The dissertation focuses on how individual non-citizens residing illegally in the country perceive their health status, what wishes they have regarding healthcare, and whether these wishes are fulfilled. The individual perspective is used instead of the more common concepts of health and healthcare needs, which are based more on the care-giver perspective.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Howard Jorge Balbi, MD 655 Deer Park Ave, Babylon, NY 11702-1314 Ph: (631) 321-2100 | Dr Howard Jorge Balbi, MD 655 Deer Park Ave, Babylon, NY 11702-1314 Ph: (631) 321-2100 |
News Archive
Aegera Therapeutics Inc. released today encouraging survival data from the Phase 1 portion of its Phase 1-2 Study of the novel targeted therapeutic, AEG35156, given in combination with sorafenib in patients with advanced hepatocellular carcinoma (primary liver cancer).
Over 6,500 new cases of bladder cancer in Europe are caused by exposure to chemicals called trihalomethanes (THM) found in drinking water. This number adds up to almost 5% of all bladder cancers in the continent. The study, published in the journal Environmental Health Perspectives in January 2020, is a pioneering attempt to establish the levels of these chemicals in tap water supplied in 26 countries in the European Union.
Gen-Probe Incorporated today announced that the US Food and Drug Administration (FDA) has granted an EUA (emergency use authorization) for its test, the Prodesse ProFlu-ST(TM), to be used in CLIA high complexity laboratories for the diagnosis of 2009 H1N1 influenza virus infection, aided by an algorithm that relies on seasonal influenza A/H1 virus and seasonal influenza A/H3 virus results, from a single sample in individuals who are diagnosed with influenza A by currently available FDA-cleared or authorized devices.
The dissertation focuses on how individual non-citizens residing illegally in the country perceive their health status, what wishes they have regarding healthcare, and whether these wishes are fulfilled. The individual perspective is used instead of the more common concepts of health and healthcare needs, which are based more on the care-giver perspective.
› Verified 5 days ago
Marion B Rose, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 500 W Main St, Suite 204, Babylon, NY 11702 Phone: 631-539-5400 Fax: 631-539-5401 | |
Dr. Dmitriy Vaysman, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 655 Deer Park Ave, Babylon, NY 11702 Phone: 631-321-2100 Fax: 631-321-2246 | |
Edward H Tom, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 50 N Carll Ave, Babylon, NY 11702 Phone: 631-661-3693 Fax: 631-661-3734 | |
Dr. Sarita Duchatelier, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 655 Deer Park Ave, Babylon, NY 11702 Phone: 631-321-2100 Fax: 631-321-2246 | |
Rohit Talwar, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 500 West Main Street, Nslij Center For Specialty Care, Suite 204, Babylon, NY 11702 Phone: 631-539-5400 Fax: 631-539-5401 | |
Michael T Pugliese, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 655 Deer Park Ave, Babylon, NY 11702 Phone: 631-321-2100 Fax: 631-321-2246 | |
Eleonor Gutierrez Lazo, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 400 West Main Street, Suite 328, Babylon, NY 11702 Phone: 631-376-1002 Fax: 631-376-1004 |